Ally Bridge Group »

Urogen Pharma shares owned by Ally Bridge Group

Quarter-by-quarter ownership of Urogen Pharma (URGN) shares owned by Ally Bridge Group from 13F filings

Historical chart of Ally Bridge Group investment in Urogen Pharma

Tip: Access up to 7 years of quarterly data

All positions including Urogen Pharma held by Ally Bridge Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Urogen Pharma by Ally Bridge Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.6M 202k 17.98

More positions owned by Ally Bridge Group

Soleno Therapeutics (SLNO)
Praxis Precision Medicines I Com New (PRAX)
Minerva Neurosciences Com New (NERV)
Ovid Therapeutics (OVID)
Compass Pathways Sponsored Ads (CMPS)
Tarsus Pharmaceuticals (TARS)
Solid Biosciences Com New (SLDB)
Compass Therapeutics Call Option (CMPX)
Promis Neurosciences Com Shs (PMN)
Edgewise Therapeutics (EWTX)
Uniqure Nv SHS Call Option (QURE)
Eupraxia Pharmaceuticals (EPRX)
Cytomx Therapeutics (CTMX)
Inventiva Sa Ads (IVA)
Perspective Therapeutics Com New (CATX)

View all positions for Ally Bridge Group

Top funds holding Urogen Pharma

Rtw Investments
BlackRock
Toronto-Dominion Bank
Morgan Stanley
Kynam Capital Management
Leucadia National Corporation
Silverarc Capital Management
Paradigm Biocapital Advisors
SG Americas Securities
Acorn Capital Advisors
Opaleye Management
American Century Companies
Menora Mivtachim Holdings
Healthcare Of Ontario Pension Plan Trust Fund
D. E. Shaw & Co

View all funds holding Urogen Pharma